Influence of the screening programme
| Cohort A | Cohort B | P value | |
| Number of biliary atresia cases | 50 | 68 | |
| Patients who underwent Kasai procedure | 34 (68.0%) | 57 (83.8%) | <0.05 |
| Age at diagnosis ±SD (days) | 81±12 | 56±15 | <0.05 |
| Length of stay ±SD (days) | 49±21 | 44±20 | <0.05 |
| Medical fee ±SD (¥) | 48 850±12 387 | 47 752±18 121 | <0.05 |
| Jaundice-free | 16 (47.1%) | 31 (54.4%) | <0.05 |
| Postsurgical complications | 20 (58.8%) | 30 (52.6%) | <0.05 |
| Liver transplantation | 13 (38.2%) | 23 (40.4%) | >0.05 |
| 2-year native liver survival rate | 15 (44.4%) | 30 (52.6%) | <0.05 |
| Death | 7 (20.6%) | 6 (10.5%) | <0.05 |
| Overall survival | 27 (79.4%) | 51 (89.5%) | <0.05 |
Cohort A: patients diagnosed between 2013 and 2014 and born in Shenzhen; cohort B: patients diagnosed between 2015 and 2017 and born in Shenzhen.
¥ is China’s monetary unit, and ¥1 is equal to US$0.14.
Overall survival was the sum total of patients who survived after liver transplantation and patients who survived with a native liver.